Enwei Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	298.09	362.31	370.27	236.12	341.58	64.25
Trading Asset Securities	176.72	171.28	144.72	157.16	236.56	14.4
Cash & Short-Term Investments	474.81	533.58	515	393.28	578.14	78.65
Cash Growth	-9.27%	3.61%	30.95%	-31.97%	635.07%	1.59%
Accounts Receivable	282.99	309.72	296.53	265	245.28	192.91
Other Receivables	4.32	3.06	3.69	3.99	4.17	3.98
Receivables	287.32	312.78	300.22	268.98	249.45	196.89
Inventory	128.28	101.1	115.55	107.37	104.65	110.01
Other Current Assets	29.61	28	21.27	17.23	25.06	28.21
Total Current Assets	920.02	975.46	952.04	786.86	957.29	413.77
Property, Plant & Equipment	273.52	264.9	246.55	231.12	240	241.77
Long-Term Investments	20	20	0.37	0.37	0.35	0.42
Goodwill	100.55	100.55	100.55	100.55	100.55	100.55
Other Intangible Assets	113.26	117.28	133.37	148.04	42.08	47.45
Long-Term Deferred Tax Assets	3.91	3.89	4.64	3.05	1.8	1.74
Long-Term Deferred Charges	12.83	13.45	8.7	10.68	16.83	18.28
Other Long-Term Assets	54.79	55.13	58.3	56.81	47.18	45.11
Total Assets	1,499	1,551	1,505	1,337	1,406	869.09
Accounts Payable	51.05	56.48	49.49	30.94	36.88	33.64
Accrued Expenses	26.73	29.38	132.83	141.69	141.02	128.52
Current Portion of Long-Term Debt	186.97	186.6	10.09	-	-	-
Current Portion of Leases	-	-	1.27	0.88	-	-
Current Income Taxes Payable	5.25	17.93	6.52	10.21	11.23	8.19
Current Unearned Revenue	24.49	19.73	24.61	14.01	28.15	16.15
Other Current Liabilities	95.78	144.87	13.6	12.04	10.31	12.73
Total Current Liabilities	390.26	454.99	238.42	209.77	227.58	199.22
Long-Term Debt	-	-	185	-	-	-
Long-Term Leases	0.93	1.44	1.52	0.46	-	-
Long-Term Unearned Revenue	8.02	8.79	9.96	11.92	14.05	15.88
Long-Term Deferred Tax Liabilities	13.46	12.64	11.96	12.17	11.45	11.74
Total Liabilities	412.67	477.86	446.86	234.31	253.08	226.84
Common Stock	102.89	102.89	102.89	70.14	70.14	52.6
Additional Paid-In Capital	631.86	630.96	638.71	671.51	664.63	239.22
Retained Earnings	385.86	373.35	375.25	392.32	418.23	350.43
Treasury Stock	-34.4	-34.4	-59.18	-30.78	-	-
Total Common Equity	1,086	1,073	1,058	1,103	1,153	642.25
Shareholders' Equity	1,086	1,073	1,058	1,103	1,153	642.25
Total Liabilities & Equity	1,499	1,551	1,505	1,337	1,406	869.09
Total Debt	187.9	188.04	197.88	1.34	-	-
Net Cash (Debt)	286.91	345.54	317.12	391.94	578.14	78.65
Net Cash Growth	-11.88%	8.96%	-19.09%	-32.21%	635.07%	1.59%
Net Cash Per Share	2.76	3.35	3.14	3.81	6.85	1.01
Filing Date Shares Outstanding	102.92	112.39	101.08	100.99	103.8	77.85
Total Common Shares Outstanding	102.92	112.39	101.08	102.76	103.8	77.85
Working Capital	529.76	520.47	713.62	577.09	729.7	214.55
Book Value Per Share	10.55	9.55	10.46	10.74	11.11	8.25
Tangible Book Value	872.4	854.97	823.74	854.59	1,010	494.25
Tangible Book Value Per Share	8.48	7.61	8.15	8.32	9.73	6.35
Buildings	-	-	289.03	287.63	275.1	274.06
Machinery	-	-	301.77	302.77	271.99	263.51
Construction In Progress	-	-	40.37	8.82	35.68	23.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.